Digital tool for personalized follow-up care after stroke
Rehabkompassen® - a Novel Digital Tool for Facilitating Patient-tailored Rehabilitation in the Post-acute Continuum of Care After Stroke - A Multicenter Pragmatic Randomized Controlled Trial
This study is testing a digital tool called Rehabkompassen® to see if it can help people recovering from a stroke improve their daily activities and quality of life compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1106 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Umeå University Academic / other |
| Locations | 1 site (Umeå) |
| Trial ID | NCT04915027 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a digital follow-up tool, Rehabkompassen®, in enhancing patient-tailored rehabilitation for individuals recovering from stroke. Participants will be randomized into two groups: one receiving standard care with the digital tool and the other receiving standard care with a Post-Stroke Checklist. The study will assess improvements in daily and social activities, health-related quality of life, and cost-effectiveness over a 12-month period. The trial will involve 1106 participants across multiple centers from 2022 to 2026.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 or older who are within four months post-stroke and have been discharged from acute care.
Not a fit: Patients who are unable to participate in evaluations or do not have access to necessary technology will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and rehabilitation outcomes for stroke survivors.
How similar studies have performed: Previous studies have shown promise in using digital tools for rehabilitation, but this specific approach with Rehabkompassen® is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria are 1. Adults aged 18 years or older. 2. With a stroke diagnosis Time since stroke onset: 3a) For the big RCT group, Individuals must be within the first 4 months after stroke, starting from Day 1 after the occurrence of the stroke. 3b) For primary care group, Individuals 3 months after stroke Exclusion criteria are 1. Unable to answer the evaluation questions. 2. Unable to see the Rehabkompassen®graph. 3. Not using BankID, an e-identification tool commonly used in Sweden.
Where this trial is running
Umeå
- Umeå University Hospital — Umeå, Sweden (Recruiting)
Study contacts
- Principal investigator: Xiaolei Hu, MD PhD — Umeå University
- Study coordinator: Xiaolei Hu, MD PhD
- Email: xiaolei.hu@umu.se
- Phone: +46 90 785 00 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.